FMP

FMP

Enter

CNSP - CNS Pharmaceuticals,...

photo-url-https://images.financialmodelingprep.com/symbol/CNSP.png

CNS Pharmaceuticals, Inc.

CNSP

NASDAQ

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

0.106 USD

0.0037 (3.5%)

CNSP Ratings

Overall Rating

2

Discounted Cash Flow

3

Return on Equity

1

Return on Assets

1

Debt to Equity

4

Price to Earnings

1

Price to Book

4

Upgrades & Downgrades

We are unable to load this data!

fmp-logo

Price Targets

We are unable to load the data!

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep